Early Immunosuppressive Therapy on the Course of Vogt-Koyanagi-Harada Disease
Status:
Unknown status
Trial end date:
2019-03-31
Target enrollment:
Participant gender:
Summary
This prospective study will include patients with Vogt-Koyanagi-Harada disease from disease
onset, treated with early systemic high-dose corticosteroid and immunosuppressive therapy.
Clinical and subclinical signs of disease activity added with electroretinogram exams,
through predefined intervals, will be evaluated through a minimum 12-month follow-up.
Phase:
N/A
Details
Lead Sponsor:
University of Sao Paulo
Collaborator:
Fundação de Amparo à Pesquisa do Estado de São Paulo